Original site: www.cdc.gov/sickle-cell/hcp/articles/index.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

← View on RestoredCDC.org View on cdc.gov ↗
Comparison timestamp: 2025-05-02 19:12:50 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/sickle-cell/hcp/articles/index.html
Live cdc.gov URL ↗: https://www.cdc.gov/sickle-cell/hcp/articles/index.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged. 
    Original site: www.cdc.gov/sickle-cell/hcp/articles/index.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
    [More]
    About Us Report Bug Compare Content
  Skip directly to site content Skip directly to search
          An official website of the United States government
        Here's how you know
              Official websites use .gov
              A .gov website belongs to an official government organization in the United States.
              Secure .gov websites use HTTPS
              A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
        Sickle Cell Disease (SCD)
          Explore Topics
        Search
          Search
          Clear Input
        For Everyone
          * About
          * Data and Statistics
          * Communication Resources
          * Steps to Better Health Toolkit
          * What Is Sickle Cell Trait?
          * Complications of Sickle Cell Disease
          * Sickle Cell Data Collection (SCDC) Program
          * Real Stories from People Living with Sickle Cell Disease
          * Real Stories From People Living with Sickle Cell Disease
          * View all
        Health Care Providers
          * Scientific Articles about Sickle Cell Disease
          * Sickle Cell Information for Healthcare Providers
          * View all
        View All
      search close search
          search
    Sickle Cell Disease (SCD) Menu Close
    Sickle Cell Disease (SCD) Menu
          search
              For Everyone
                  * About
                  * Data and Statistics
                  * Communication Resources
                  * Steps to Better Health Toolkit
                  * What Is Sickle Cell Trait?
                  * Complications of Sickle Cell Disease
                  * Sickle Cell Data Collection (SCDC) Program
                  * Real Stories from People Living with Sickle Cell Disease
                  * Real Stories From People Living with Sickle Cell Disease
                  * View All Home
              Health Care Providers
                  * Scientific Articles about Sickle Cell Disease
                  * Sickle Cell Information for Healthcare Providers
                  * View All
        View All Sickle Cell Disease (SCD)
    Scientific Articles about Sickle Cell Disease Sickle Cell Information for Healthcare Providers View All
August 13, 2024
March 11, 2025
  Scientific Articles about Sickle Cell Disease
          At a glance
          Below is a list of recent scientific articles generated from CDC programs and activities.
        Articles about SCD
        2025
        Changes in Acute Care Use among People with Sickle Cell Disease after Adoption of a Prescription Drug Monitoring Program. Blood Adv. 2025:bloodadvances.2024013594. McGee BT, Attell BK, Marton J, Harris A, Alfrey B, Cohen L, Snyder AB.
        2024
        Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease. Attell BK, Plaxco AP, Zhou M, Valle J, Reeves SL, Patel PN, Latta K, Smeltzer MP, Snyder AB. BMC Emerg Med. 2024 Jul 29;24(1):134. doi: 10.1186/s12873-024-01043-5. PMID: 39075379; PMCID: PMC11287848.
        The Prevalence of Sickle Cell Disease in Colorado and Methodologies of the Colorado Sickle Cell Data Collection Program: Public Health Surveillance Study. JMIR Public Health Surveill. 2024;10:e64995. Miller JI, Hassell KL, Kellar-Guenther Y, Quesada S, West R, Sontag M.
        Examining community-level social vulnerability and emergency department use for people living with sickle cell disease in Michigan. Swallow J, Latta K, Plegue M, Peng HK, Tipirneni R, Smith D, Lê-Scherban F, Dombkowski KJ, Reeves SL. Pediatr Blood Cancer. 2024;e31225. doi: 10.1002/pbc.31225. Epub ahead of print. PMID: 39054678.
        Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study. Pediatr Blood Cancer. 2024;71(7):e31042. Shi JS, Sutaria A, Lakshmanan S, Attell B, Zhou M, Tang A, Eckman J, Snyder A.
        Prevalence, mortality, and access to care for chronic kidney disease in Medicaid-enrolled adults with sickle cell disease in California: Retrospective cohort study. Valle J, Lebensburger JD, Garimella PS, Gopal S. JMIR Public Health Surveill. 2024;10:e57290. doi:10.2196/57290.
        COVID-19 Immunization Coverage Among People With Sickle Cell Disease. JAMA Netw Open. 2024;7(1):e2351618. Peng HK, Dombkowski KJ, Plegue MA, Latta K, Malosh R, Creary MS, Reeves SL.
        Emergency department 30-day emergency department revisits among people with sickle cell disease: variations in characteristics. Rushing M, Horiuchi S, Zhou M, Kavanagh PL, Reeves SL, Snyder A, Paulukonis S. Pediatr Blood Cancer. 2024;e31188. doi:10.1002/pbc.31188.
        Improving the Lives of People with Sickle Cell Disease: Community Organizations and Epidemiologists Working Together. Prog Community Health Partnersh. 2024;18(3):371-380. Young AJ, Maresh A, Pope S, Blaylark R, Lakshmanan S, Stephens L, Aderojou R, Meier E, Gibson G, Okolo A, Cromartie S, Coker N, Paulukonis S, Fields J, Kaur M, Desai J.
        Medicaid coverage in early childhood for children with sickle cell disease. Horiuchi SS, Reeves SL, Plaxco AP, Peng HK, Zhou M, Kayle M, Hulihan M. JAMA Netw Open. 2024;7(7):e2421491. doi:10.1001/jamanetworkopen.2024.21491.
          View LargerDownload
          Visual abstract for publication: Improving the Lives of People with Sickle Cell Disease: Community Organizations and Epidemiologists Working Together.
          CDC’s Sickle Cell Data Collection Program builds bridges between community-based organizations and scientists. What did we learn from these partnerships?
          -Priorities trust-building
          -Establish shared goals and define expectations
          -Leverage strengths for mutual benefit
          -Incorporate community voices from the beginning
          -Foster open communication
          -Seek out diverse partnerships and perspectives
          Consider how these lessons can help your program build stronger partnerships.
          Young AJ, Maresh A, Pope S, et al. Improving the Lives of People with Sickle Cell Disease: Community Organizations and Epidemiologists Working Together. Prog Community Health Partnersh. 2024;18(3):371-380.
          Show Text Description
        National Quality Indicators in Pediatric Sickle Cell Anemia. Pediatrics. 2024 Apr 1;153(4):e2022060804. Anderson AT, Mack WJ, Horiuchi SS, Paulukonis S, Zhou M, Snyder AB, Doctor JN, Kipke M, Coates T, Freed G.
        Opioid Use After First Opioid Prescription in Children With Sickle Cell Disease. JAMA Pediatr. 2024;178(4):408-410. Snyder AB, Zhou M, Attell BK, Cohen LL, Carter S, Bock F, Dampier C.
        Examining community-level social vulnerability and emergency department use for people living with sickle cell disease in Michigan. Pediatr Blood Cancer. 2024;e31225. Swallow J, Latta K, Plegue M, Peng HK, Tipirneni R, Smith D, Lê-Scherban F, Dombkowski KJ, Reeves SL.
        Acute care utilization among individuals with sickle cell disease and related cardiopulmonary and renal complications.
        Singh A, Brousseau DC, Dasgupta M, Shet AS, Field JJ, Brandow AM. PLoS One. 2024 Apr 16;19(4):e0297469. doi: 10.1371/journal.pone.0297469. PMID: 38626063; PMCID: PMC11020686.
        PLoS One. 2024;19(4):e0297469. Singh A, Brousseau DC, Dasgupta M, Shet AS, Field JJ, Brandow AM.
        Assessing patterns of telehealth use among people with sickle cell disease enrolled in Medicaid during the start of the COVID-19 pandemic.
        Assessing patterns of telehealth use among people with sickle cell disease enrolled in Medicaid during the start of the COVID-19 pandemic. Telemed J E Health. 2024. Reeves SL, Plegue M, Patel PN, Paulukonis ST, Horiuchi SS, Zhou M, Attell BK, Pace BS, Snyder AB, Plaxco AP, Mukhopadhyay A, Smeltzer MP, Ellimootil CS, Hulihan M.
        Reeves SL, Plegue M, Patel PN, Paulukonis ST, Horiuchi SS, Zhou M, Attell BK, Pace BS, Snyder AB, Plaxco AP, Mukhopadhyay A, Smeltzer MP, Ellimootil CS, Hulihan M. Telemed J E Health. 2024 Apr 11. doi: 10.1089/tmj.2023.0422. Epub ahead of print. PMID: 38603584.
 
        Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease. BMC Emerg Med. 2024;24(1):134. Attell BK, Plaxco AP, Zhou M, Valle J, Reeves SL, Patel PN, Latta K, Smeltzer MP, Snyder AB.
        Prevalence, mortality, and access to care for chronic kidney disease in Medicaid-enrolled adults with sickle cell disease in California: Retrospective cohort study. JMIR Public Health Surveill. 2024;10:e57290. Valle J, Lebensburger JD, Garimella PS, Gopal S.
        Emergency department 30-day emergency department revisits among people with sickle cell disease: variations in characteristics. Pediatr Blood Cancer. 2024;e31188. Rushing M, Horiuchi S, Zhou M, Kavanagh PL, Reeves SL, Snyder A, Paulukonis S.
        Medicaid coverage in early childhood for children with sickle cell disease. JAMA Netw Open. 2024;7(7):e2421491. Horiuchi SS, Reeves SL, Plaxco AP, Peng HK, Zhou M, Kayle M, Hulihan M.
        Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability — Sickle Cell Data Collection Program, 11 States, 2016–2020.
        Kayle M, Blewer AL, Pan W, et al. MMWR Morb Mortal Wkly Rep 2024;73:248–254. DOI: http://dx.doi.org/10.15585/mmwr.mm7312a1.
        MMWR Morb Mortal Wkly Rep 2024;73:248–254. Kayle M, Blewer AL, Pan W, et al.
          View LargerDownload
          Visual abstract for publication: Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability — Sickle Cell Data Collection Program, 11 States, 2016–2020.
          Children with sickle cell disease (SCD) have complex health needs that benefit from ongoing specialized health care
          2 of 3 newborns with SCD are born to mothers who live in U.S. counties with high levels of social vulnerability* Social vulnerability includes factors such as poverty, lack of vehicle access, and crowded housing
          Communities can provide support by:
          -Developing medical transportation reimbursement programs
          -Developing innovative comprehensive care models
          *State newborn screening program records, Sickle Cell Data Collection Program, 2016-2020
          bit.ly/mm7312a1
          March 28, 2024
          Show Text Description
        COVID-19 immunization coverage among people with sickle cell disease.
        Peng HK, Dombkowski KJ, Plegue MA, Latta K, Malosh R, Creary MS, Reeves SL. JAMA Netw Open. 2024 Jan 2;7(1):e2351618. doi: 10.1001/jamanetworkopen.2023.51618.
        JAMA Netw Open. 2024;7(1):e2351618. Peng HK, Dombkowski KJ, Plegue MA, Latta K, Malosh R, Creary MS, Reeves SL.
        2023
        Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999-2020. AJPM Focus. 2023;3(1):100158. Attell BK, Barrett PM, Pace BS, McLemore ML, McGee BT, Oshe R, DiGirolamo AM, Cohen LL, Snyder AB.
        Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. JMIR Public Health Surveill. 2023;9:e42816. Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J.
        Timeliness of Opioid Administration for Pain in the Emergency Department for Adults with Sickle Cell Disease.
        Blood. 2023; 142 (Supplement 1): 3738. Singh A, Brousseau D.C., Osinski K, Brandow A.M.
        Evaluating the discriminatory ability of the Sickle Cell Data Collection program's administrative claims case definition in identifying adults with sickle cell disease: validation study.
        Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J. JMIR Public Health Surveill. 2023 Jun 28;9:e42816. doi: 10.2196/42816.
        JMIR Public Health Surveill. 2023;9:e42816. Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J.
        Common data model for sickle cell disease surveillance: considerations and implications.
        Smeltzer MP, Reeves SL, Cooper WO, Attell BK, Strouse JJ, Takemoto CM, Kanter J, Latta K, Plaxco AP, Davis RL, Hatch D, Reyes C, Dombkowski K, Snyder A, Paulukonis S, Singh A, Kayle M. JAMIA Open. 2023 May 27;6(2):ooad036. doi: 10.1093/jamiaopen/ooad036.
        JAMIA Open. 2023;6(2):ooad036. Smeltzer MP, Reeves SL, Cooper WO, Attell BK, Strouse JJ, Takemoto CM, Kanter J, Latta K, Plaxco AP, Davis RL, Hatch D, Reyes C, Dombkowski K, Snyder A, Paulukonis S, Singh A, Kayle M.
        Increasing visibility of sickle cell disease in Indiana: establishing baseline prevalence using integrated data from multiple sources.
        Okolo AI, Jacob SA, Dixon BE, Valvi NR, Janson IA, Hardesty BM. Public Health Rep. 2023 May 26:333549231170229. doi: 10.1177/00333549231170229.
        Public Health Rep. 2023;333549231170229. Okolo AI, Jacob SA, Dixon BE, Valvi NR, Janson IA, Hardesty BM.
        Case ascertainment of sickle cell disease using surveillance or single administrative database case definitions.
        Reeves SL, Horiuchi S, Zhou M, Paulukonis S, Snyder A, Wilson-Frederick S, Hulihan M. Public Health Rep. 2023 May 19:333549231166465. doi: 10.1177/00333549231166465.
        Public Health Rep. 2023;333549231166465. Reeves SL, Horiuchi S, Zhou M, Paulukonis S, Snyder A, Wilson-Frederick S, Hulihan M.
        COVID-19 infection and outcomes in newborn screening cohorts of sickle cell trait and sickle cell disease in Michigan and Georgia.
        Paulukonis ST, Snyder A, Smeltzer MP, Sutaria AN, Hurden I, Latta K, Chennuri S, Vichinsky E, Reeves SL. J Pediatr Hematol Oncol. 2023 May 1;45(4):174-180. doi: 10.1097/MPH.000000000000267.
        J Pediatr Hematol Oncol. 2023;45(4):174-180. Paulukonis ST, Snyder A, Smeltzer MP, Sutaria AN, Hurden I, Latta K, Chennuri S, Vichinsky E, Reeves SL.
        Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019.
        Tang AY, Zhou M, Maillis AN, Lai KW, Lane PA, Snyder AB. Pediatr Blood Cancer. 2023 Mar;70(3):e30152. doi: 10.1002/pbc.30152.
        Pediatr Blood Cancer. 2023;70(3):e30152. Tang AY, Zhou M, Maillis AN, Lai KW, Lane PA, Snyder AB.
        2022
        Surveillance for the Rare Condition of Sickle Cell Disease in Wisconsin. WMJ. 2022;121(4):297-300. Singh A, Dasgupta M, Retherford D, Baker M, Hulihan M, Brandow AM.
        Telehealth Use Before and During the COVID-19 Pandemic Among Children with Sickle Cell Anemia. Telemed J E Health. 2022;28(8):1166-1171. Reeves SL, Patel PN, Madden B, Ng S, Creary SE, Smith D, Ellimoottil C.
        Use of recommended health care measures to prevent selected complications of sickle cell anemia in children and adolescents — Selected U.S. states, 2019.
        Schieve LA, Simmons GM, Payne AB, et al. MMWR Morb Mortal Wkly Rep 2022;71:1241–1246. doi: http://dx.doi.org/10.15585/mmwr.mm7139e1.
        MMWR Morb Mortal Wkly Rep 2022;71:1241–1246. Schieve LA, Simmons GM, Payne AB, et al.
          * Vital Signs: Preventing Sickle Cell Anemia Complications in Children
        Prioritizing sickle cell disease.
        Lewis L. Hsu, W. Craig Hooper, Laura A. Schieve. Pediatrics December 2022; 150 (6): e2022059491. 10.1542/peds.2022-059491
        Pediatrics December 2022;150(6): e2022059491. Lewis L. Hsu, W. Craig Hooper, Laura A. Schieve.
        Sickle cell disease among Latinx in California.
        Valle J, Baker JR, Madrigal D, Ferrerosa J, Paulukonis S. PLoS One. 2022 Oct 27;17(10):e0276653. doi: 10.1371/journal.pone.0276653.
        PLoS One. 2022;17(10):e0276653. Valle J, Baker JR, Madrigal D, Ferrerosa J, Paulukonis S.
        Surveillance for the rare condition of sickle cell disease in Wisconsin. Singh A, Dasgupta M, Retherford D, Baker M, Hulihan M, Brandow AM. WMJ. 2022 Dec;121(4):297-300.
        Surveillance for the rare condition of sickle cell disease in Wisconsin.
        WMJ. 2022;121(4):297-300. Singh A, Dasgupta M, Retherford D, Baker M, Hulihan M, Brandow AM.
        Surveillance for sickle cell disease — Sickle Cell Data Collection program, two states, 2004–2018.
        Snyder AB, Lakshmanan S, Hulihan MM, et al. MMWR Surveill Summ 2022;71(No. SS-9):1–18. doi: http://dx.doi.org/10.15585/mmwr.ss7109a1.
        MMWR Surveill Summ 2022;71(No. SS-9):1–18. Snyder AB, Lakshmanan S, Hulihan MM, et al.
        COVID-19 and sickle cell disease-related deaths reported in the United States.
        Payne AB, Schieve LA, Abe K, Hulihan M, Hooper WC, Hsu LL. Public Health Rep. 2022 Mar-Apr;137(2):234-238. doi: 10.1177/00333549211063518.
        Public Health Rep. 2022;137(2):234-238. Payne AB, Schieve LA, Abe K, Hulihan M, Hooper WC, Hsu LL.
        Hematologist encounters among Medicaid patients who have sickle cell disease.
        Horiuchi SS, Zhou M, Snyder A, Paulukonis ST. Blood Adv. 2022 Sep 13;6(17):5128-5131. doi: 10.1182/bloodadvances.2022007622.
        Blood Adv. 2022;6(17):5128-5131. Horiuchi SS, Zhou M, Snyder A, Paulukonis ST.
        2021
        Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009-2015.
        Payne AB, Adamkiewicz TV, Grosse SD, Steffens A, Shay DK, Reed C, Schieve LA. Pediatr Blood Cancer. 2021 Dec;68(12):e29351. doi: 10.1002/pbc.29351.
        Pediatr Blood Cancer. 2021;68(12):e29351. Payne AB, Adamkiewicz TV, Grosse SD, Steffens A, Shay DK, Reed C, Schieve LA.
        Improving outcomes for patients with sickle cell disease in the United States: making the case for more resources, surveillance, and longitudinal data.
        Kanter J, Meier ER, Hankins JS, Paulukonis ST, Snyder AB. JAMA Health Forum. 2021 Oct 1;2(10):e213467. doi: 10.1001/jamahealthforum.2021.3467.
        JAMA Health Forum. 2021;2(10):e213467. Kanter J, Meier ER, Hankins JS, Paulukonis ST, Snyder AB.
        Hydroxyurea use after transitions of care among young adults with sickle cell disease and Tennessee Medicaid insurance.
        Mathias JG, Nolan VG, Klesges LM, Badawy SM, Cooper WO, Hankins JS, Smeltzer MP. JAMA Netw Open. 2021 Oct 1;4(10):e2128971. doi: 10.1001/jamanetworkopen.2021.28971.
        JAMA Netw Open. 2021;4(10):e2128971. Mathias JG, Nolan VG, Klesges LM, Badawy SM, Cooper WO, Hankins JS, Smeltzer MP.
        Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease.
        Wong TE, Valle J, Paulukonis S. Health Sci Rep. 2021 Jul 14;4(3):e323. doi: 10.1002/hsr2.323.
        Health Sci Rep. 2021;4(3):e323. Wong TE, Valle J, Paulukonis S.
        2020
        Coronavirus disease among persons with sickle cell disease, United States, March 20–May 21, 2020.
        Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, Payne AB, Peacock G, Schieve LA. Emerging Infectious Diseases. 2020 Oct. doi: 10.3201/eid2610.202792.
        Emerging Infectious Diseases. 2020. Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, Payne AB, Peacock G, Schieve LA.
        Trends in sickle cell disease-related mortality in the United States, 1979–2017.
        Payne AB, Mehal JM, Chapman C, Haberling DL, Richardson LC, Bean CJ, Hooper WC. Annals of Emergency Medicine. 2020; 76 (3S):S28-S36
        Annals of Emergency Medicine. 2020;76(3S):S28-S36. Payne AB, Mehal JM, Chapman C, Haberling DL, Richardson LC, Bean CJ, Hooper WC.
        Using surveillance to determine the number of individuals with sickle cell disease in California and Georgia, 2005-2016.
        Aluc A, Zhou M, Paulukonis ST, Snyder AB, Wong D, Hulihan MM. [published online ahead of print, 2020 Aug 12]. Pediatr Hematol Oncol. 2020;1-5. doi:10.1080/08880018.2020.1779886
        Pediatr Hematol Oncol. 2020;1-5. Aluc A, Zhou M, Paulukonis ST, Snyder AB, Wong D, Hulihan MM.
        Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
        Kayle M, Valle J, Paulukonis S, Holl JL, Tanabe P, French DD, Garg R, Liem RI, Badawy SM, Treadwell MJ. Pediatr Blood Cancer. 2020 May;67(5):e28152.
        Pediatr Blood Cancer. 2020;67(5):e28152. Kayle M, Valle J, Paulukonis S, Holl JL, Tanabe P, French DD, Garg R, Liem RI, Badawy SM, Treadwell MJ.
        Acute care utilization at end of life in sickle cell disease: Highlighting the need for a palliative approach.
        Johnston EE, Adesina OO, Alvarez E, Amato H, Paulukonis S, Nichols A, Chamberlain LJ, Bhatia S. J Palliat Med. 2020 Jan;23(1):24-32.
        J Palliat Med. 2020;23(1):24-32. Johnston EE, Adesina OO, Alvarez E, Amato H, Paulukonis S, Nichols A, Chamberlain LJ, Bhatia S.
        2019
        Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease.
        Tang A, Branscomb J, Zhou M, Snyder A, Eckman J. Pediatr Blood Cancer. 2019 Oct;66(10):e27921.
        Pediatr Blood Cancer. 2019;66(10):e27921. Tang A, Branscomb J, Zhou M, Snyder A, Eckman J
        Health literacy and knowledge of chronic transfusion therapy in adolescents with sickle cell disease and caregivers.
        Yee MEM, Meyer EK, Fasano, RM, Lane PA, Josephson CD, Brega AG. Pediatr Blood Cancer. 2019 Jul;66(7):e27733.
        Pediatr Blood Cancer. 2019;66(7):e27733. Yee MEM, Meyer EK, Fasano, RM, Lane PA, Josephson CD, Brega AG.
        Understanding the complications of sickle cell disease.
        Tanabe P, Spratling R, Smith D, Grissom P, Hulihan M. American Journal of Nursing 2019 June; 119 (6) 26-35. doi: 10.1097/01.NAJ.0000559779.40570.2c
        American Journal of Nursing 2019; 119 (6) 26-35. Tanabe P, Spratling R, Smith D, Grissom P, Hulihan M.
        Improving an administrative case definition for longitudinal surveillance of sickle cell disease
        Snyder AB,Zhou M, Theodore R, Quarmyne MO, Eckman J, Lane PA. Public Health Rep. 2019 May/Jun;134(3):274-281. doi: 10.1177/0033354919839072.
        Public Health Rep. 2019;134(3):274-281. Snyder AB,Zhou M, Theodore R, Quarmyne MO, Eckman J, Lane PA.
        Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia.
        Fasano RM, Branscomb J, Lane PA, Josephson CD, Snyder AB, Eckman JR. Transfus Med. 2019 Feb 10.
        Transfus Med. 2019. Fasano RM, Branscomb J, Lane PA, Josephson CD, Snyder AB, Eckman JR.
        Facilitators and barriers to minority blood donations: A systematic review.
        Spratling R, Lawrence RH. Nurs Res. 2019 Mar 1. [Epub ahead of print].
        Nurs Res. 2019. Spratling R, Lawrence RH.
        2018
        A strategic planning tool for increasing African American blood donation.
        Singleton A, Spratling R. Health Promot Pract. 2018 May 1:1524839918775733. doi: 10.1177/1524839918775733.
        Health Promot Pract. 2018;1524839918775733. Singleton A, Spratling R.
        Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy.
        Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Roback JD, Fasano RM. Transfusion. 2018 Apr 17. doi: 10.1111/trf.14610.
        Transfusion. 2018. Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Roback JD, Fasano RM.
        2017
        CDC Grand Rounds: Improving the lives of persons with sickle cell disease.
        Hulihan M, Hassell KL, Raphael JL, Smith-Whitley K, Thorpe P. MMWR Morb Mortal Wkly Rep. 2017 Nov 24;66(46):1269-1271. doi: 10.15585/mmwr.mm6646a2.
        MMWR Morb Mortal Wkly Rep. 2017;66(46):1269-1271. Hulihan M, Hassell KL, Raphael JL, Smith-Whitley K, Thorpe P.
        Emergency department utilization by Californians with sickle cell disease, 2005-2014.
        Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. Pediatr Blood Cancer. 2017 Jun;64(6):10.1002/pbc.26390. doi: 10.1002/pbc.26390.
        Pediatr Blood Cancer. 2017;64(6):10.1002/pbc.26390. Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM.
        Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
        Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Fasano RM. Transfusion. 2017 Nov;57(11):2738-2746. doi: 10.1111/trf.14282.
        Transfusion. 2017;57(11):2738-2746. Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Fasano RM.
        The accuracy of hospital ICD-9-CM codes for determining sickle cell disease genotype.
        Snyder AB, Lane PA, Zhou M, Paulukonis ST, Hulihan MM. J Rare Dis Res Treat. 2017;2(4):39-45.
        J Rare Dis Res Treat. 2017;2(4):39-45. Snyder AB, Lane PA, Zhou M, Paulukonis ST, Hulihan MM.
          Related PagesSickle Cell Information for Healthcare Providers
          Related Pages
        * 
        Back to Top
            * Sickle Cell Information for Healthcare Providers
  August 13, 2024
          View All Sickle Cell Disease (SCD)
    Sickle Cell Information for Healthcare Providers
  March 10, 2025
      Sources Print Share
        Facebook LinkedIn Twitter Syndicate
          Content Source:
        National Center on Birth Defects and Developmental Disabilities (NCBDDD)
      Related PagesSickle Cell Information for Healthcare Providers
      Related Pages
    * 
 
        * Sickle Cell Information for Healthcare Providers
      View All Sickle Cell Disease (SCD)
  Back to Top
    Sickle Cell Disease (SCD)
    Sickle cell disease (SCD) is a group of inherited red blood cell disorders. In SCD, the red blood cells become hard and sticky and look like a C-shaped farm tool called a “sickle.”
    View All
        For Everyone
          * About
          * Data and Statistics
          * Communication Resources
          * Steps to Better Health Toolkit
          * What Is Sickle Cell Trait?
          * Complications of Sickle Cell Disease
          * Sickle Cell Data Collection (SCDC) Program
          * Real Stories from People Living with Sickle Cell Disease
          * Real Stories From People Living with Sickle Cell Disease
          Health Care Providers
            * Scientific Articles about Sickle Cell Disease
            * Sickle Cell Information for Healthcare Providers
        Sign up for Email Updates
    Contact Us
        Contact Us
          * Call 800-232-4636
          * Contact CDC
    About CDC
        About CDC
          * Pressroom
          * Organization
          * Budget & Funding
          * Careers & Jobs
    Policies
              * Accessibility
              * External Links
              * Privacy
              * Web Policies
              * FOIA
              * OIG
              * No Fear Act
              * Nondiscrimination
              * Vulnerability Disclosure Policy
    Languages
            Languages
              * Español
            Language Assistance
                  * Español
                  * 繁體中文
                  * Tiếng Việt
                  * 한국어
                  * Tagalog
                  * Русский
                  * العربية
                  * Kreyòl Ayisyen
                  * Français
                  * Polski
                  * Português
                  * Italiano
                  * Deutsch
                  * 日本語
                  * فارسی
                  * English
    Archive
          * CDC Archive
          * Public Health Publications
    Contact Us
      Contact Us
        * Call 800-232-4636
        * Contact CDC
    About CDC
        * Pressroom
        * Organization
        * Budget & Funding
        * Careers & Jobs
        * About CDC
    Policies
        * Accessibility
        * External Links
        * Privacy
        * Web Policies
        * FOIA
        * OIG
        * No Fear Act
        * Nondiscrimination
        * Vulnerability Disclosure Policy
    Languages
      Languages
        * Español
      Language Assistance
        * Español
        * 繁體中文
        * Tiếng Việt
        * 한국어
        * Tagalog
        * Русский
        * العربية
        * Kreyòl Ayisyen
        * Français
        * Polski
        * Português
        * Italiano
        * Deutsch
        * 日本語
        * فارسی
        * English
    Archive
        * CDC Archive
        * Public Health Publications
    HHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.